Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 716

    1.

    Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

    Aziz NA, Jurgens CK, Landwehrmeyer GB, van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA; EHDN Registry Study Group.

    Neurology. 2009 Oct 20;73(16):1280-5. Epub 2009 Sep 23.PMID: 19776381 [PubMed - indexed for MEDLINE]Related articles

    2.

    Huntington disease: a tale of two genes.

    Lahiri N, Tabrizi SJ.

    Neurology. 2009 Oct 20;73(16):1254-5. Epub 2009 Sep 23. No abstract available. PMID: 19776377 [PubMed - indexed for MEDLINE]Related articles

    3.

    Weight loss in Huntington disease increases with higher CAG repeat number.

    Gilbert GJ.

    Neurology. 2009 Aug 18;73(7):572; author reply 572. No abstract available. PMID: 19687463 [PubMed - indexed for MEDLINE]Related articles

    4.

    Progress and challenges in RNA interference therapy for Huntington disease.

    Harper SQ.

    Arch Neurol. 2009 Aug;66(8):933-8. Review. Erratum in: Arch Neurol. 2009 Oct;66(10):1272. PMID: 19667213 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

    Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group.

    Neurology. 2009 Aug 4;73(5):385-92.PMID: 19652143 [PubMed - indexed for MEDLINE]Related articles

    6.

    Preimplantation genetic diagnosis of P450 oxidoreductase deficiency and Huntington Disease using three different molecular approaches simultaneously.

    Alberola TM, Bautista-Llácer R, Fernández E, Vendrell X, Pérez-Alonso M.

    J Assist Reprod Genet. 2009 May;26(5):263-71. Epub 2009 Jul 21.PMID: 19621255 [PubMed - indexed for MEDLINE]Related articles

    7.

    Polyglutamine expansion in huntingtin increases its insertion into lipid bilayers.

    Kegel KB, Schewkunow V, Sapp E, Masso N, Wanker EE, DiFiglia M, Goldmann WH.

    Biochem Biophys Res Commun. 2009 Sep 25;387(3):472-5. Epub 2009 Jul 14.PMID: 19607813 [PubMed - indexed for MEDLINE]Related articles

    8.

    Human embryonic stem cell models of Huntington disease.

    Niclis JC, Trounson AO, Dottori M, Ellisdon AM, Bottomley SP, Verlinsky Y, Cram DS.

    Reprod Biomed Online. 2009 Jul;19(1):106-13.PMID: 19573298 [PubMed - indexed for MEDLINE]Related articles

    9.

    Singleton birth after preimplantation genetic diagnosis for Huntington disease using whole genome amplification.

    Chow JF, Yeung WS, Lau EY, Lam ST, Tong T, Ng EH, Ho PC.

    Fertil Steril. 2009 Aug;92(2):828.e7-10. Epub 2009 Jun 9.PMID: 19515365 [PubMed - indexed for MEDLINE]Related articles

    10.

    Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG).

    Hendricks AE, Latourelle JC, Lunetta KL, Cupples LA, Wheeler V, Macdonald ME, Gusella JF, Myers RH.

    Am J Med Genet A. 2009 Jul;149A(7):1375-81.PMID: 19507258 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Caregiving by teens for family members with Huntington disease.

    Williams JK, Ayres L, Specht J, Sparbel K, Klimek ML.

    J Fam Nurs. 2009 Aug;15(3):273-94. Epub 2009 May 22.PMID: 19465560 [PubMed - indexed for MEDLINE]Related articles

    12.

    A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.

    Lombardi MS, Jaspers L, Spronkmans C, Gellera C, Taroni F, Di Maria E, Donato SD, Kaemmerer WF.

    Exp Neurol. 2009 Jun;217(2):312-9. Epub 2009 Mar 13.PMID: 19289118 [PubMed - indexed for MEDLINE]Related articles

    13.

    Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.

    Squitieri F, Orobello S, Cannella M, Martino T, Romanelli P, Giovacchini G, Frati L, Mansi L, Ciarmiello A.

    Eur J Nucl Med Mol Imaging. 2009 Jul;36(7):1113-20. Epub 2009 Mar 11.PMID: 19280185 [PubMed - indexed for MEDLINE]Related articles

    14.

    In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease.

    Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL.

    J Neurosci. 2009 Mar 11;29(10):3200-5.PMID: 19279257 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.

    Ermak G, Hench KJ, Chang KT, Sachdev S, Davies KJ.

    J Biol Chem. 2009 May 1;284(18):11845-53. Epub 2009 Mar 6.PMID: 19270310 [PubMed - indexed for MEDLINE]Related articles

    17.

    Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease.

    Vandenberghe W, Demaerel P, Dom R, Maes F.

    J Neurol. 2009 Jan;256(1):109-14. Epub 2009 Feb 16.PMID: 19267169 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mouse models of Huntington disease: variations on a theme.

    Ehrnhoefer DE, Butland SL, Pouladi MA, Hayden MR.

    Dis Model Mech. 2009 Mar-Apr;2(3-4):123-9.PMID: 19259385 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    A patient with early onset Huntington disease and severe cerebellar atrophy.

    Sakazume S, Yoshinari S, Oguma E, Utsuno E, Ishii T, Narumi Y, Shiihara T, Ohashi H.

    Am J Med Genet A. 2009 Feb 15;149A(4):598-601.PMID: 19253382 [PubMed - indexed for MEDLINE]Related articles

    20.

    4p16.3 haplotype modifying age at onset of Huntington disease.

    Nørremølle A, Budtz-Jørgensen E, Fenger K, Nielsen JE, Sørensen SA, Hasholt L.

    Clin Genet. 2009 Mar;75(3):244-50.PMID: 19250382 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...